补体激活-话题@MedSci

#补体激活#

9篇内容 | 725人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1592089, encodeId=d3751592089c9, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关, objectType=article, longId=733311, objectId=d355e3331156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d355e3331156, replyNumber=0, likeNumber=27, createdTime=2022-07-28, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d355e3331156, moduleTitle=ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d355e3331156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592088, encodeId=64141592088d5, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Blood：抑制D因子可阻断新冠病毒棘突蛋白引起的补体激活！, objectType=article, longId=200648, objectId=52d42006483c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52d42006483c, replyNumber=0, likeNumber=36, createdTime=2020-09-15, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52d42006483c, moduleTitle=Blood：抑制D因子可阻断新冠病毒棘突蛋白引起的补体激活！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52d42006483c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592087, encodeId=9d81159208e19, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Diabetologia：双羰基胁迫与补体激活的关系？, objectType=article, longId=197825, objectId=b1f919e82577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1f919e82577, replyNumber=0, likeNumber=35, createdTime=2020-07-22, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1f919e82577, moduleTitle=Diabetologia：双羰基胁迫与补体激活的关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1f919e82577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592086, encodeId=45cf1592086a8, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究, objectType=article, longId=186439, objectId=a05e1864396c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05e1864396c, replyNumber=0, likeNumber=29, createdTime=2020-01-18, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05e1864396c, moduleTitle=Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a05e1864396c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592085, encodeId=940b159208555, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Blood：eculizumab阻断补体激活明显改善高TA-TMA风险患者HSCT后的存活率, objectType=article, longId=186299, objectId=325e1862994a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=325e1862994a, replyNumber=0, likeNumber=29, createdTime=2020-01-16, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=325e1862994a, moduleTitle=Blood：eculizumab阻断补体激活明显改善高TA-TMA风险患者HSCT后的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=325e1862994a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592084, encodeId=d818159208476, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Blood：补体激活与抗磷脂抗体综合征的血栓形成事件, objectType=article, longId=184612, objectId=642c18461246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642c18461246, replyNumber=0, likeNumber=31, createdTime=2019-12-13, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642c18461246, moduleTitle=Blood：补体激活与抗磷脂抗体综合征的血栓形成事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=642c18461246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592083, encodeId=41a31592083a7, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=Blood：多反应性IgM通过PF4/肝素复合物激活经典信号通路启动补体激活, objectType=article, longId=150933, objectId=1e7815093336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7815093336, replyNumber=0, likeNumber=35, createdTime=2018-10-14, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7815093336, moduleTitle=Blood：多反应性IgM通过PF4/肝素复合物激活经典信号通路启动补体激活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7815093336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592082, encodeId=70c815920822a, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=PLoS One：中枢浆液脉络膜视网膜病变中的系统性补体激活, objectType=article, longId=104698, objectId=783410469841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=783410469841, replyNumber=0, likeNumber=29, createdTime=2017-07-07, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=783410469841, moduleTitle=PLoS One：中枢浆液脉络膜视网膜病变中的系统性补体激活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=783410469841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1592081, encodeId=86831592081b6, content=<a href='/topic/show?id=f7b7901238d' target=_blank style='color:#2F92EE;'>#补体激活#</a>, objectTitle=J Endod：盖髓材料引发的补体激活对炎症和牙髓干细胞募集效果显著, objectType=article, longId=100001, objectId=d1cf1000010e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1cf1000010e, replyNumber=0, likeNumber=35, createdTime=2017-05-29, rootId=0, userName=sodoo, userId=63f218082312, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1cf1000010e, moduleTitle=J Endod：盖髓材料引发的补体激活对炎症和牙髓干细胞募集效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1cf1000010e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

补体激活

2020-05-29

sodoo (审核中...)

前往app查看评论内容

#补体激活#

ATVB：补体激活酶MASP-2水平与静脉血栓栓塞的风险相关

2022-07-28

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Blood：抑制D因子可阻断新冠病毒棘突蛋白引起的补体激活！

2020-09-15

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Diabetologia：双羰基胁迫与补体激活的关系？

2020-07-22

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Sci Rep：良性前列腺增生生长过程中通过自身抗原识别的补体激活研究

2020-01-18

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Blood：eculizumab阻断补体激活明显改善高TA-TMA风险患者HSCT后的存活率

2020-01-16

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Blood：补体激活与抗磷脂抗体综合征的血栓形成事件

2019-12-13

sodoo (审核中...)

前往app查看评论内容

#补体激活#

Blood：多反应性IgM通过PF4/肝素复合物激活经典信号通路启动补体激活

2018-10-14

sodoo (审核中...)

前往app查看评论内容

#补体激活#

PLoS One：中枢浆液脉络膜视网膜病变中的系统性补体激活

2017-07-07

sodoo (审核中...)

前往app查看评论内容

#补体激活#

J Endod：盖髓材料引发的补体激活对炎症和牙髓干细胞募集效果显著

2017-05-29

科室
- - 订阅+
  - 更多科室
工具
服务